Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Bell Pharmaceuticals, Inc
FDA Inspection
•Bell Pharmaceuticals, Inc•May 15, 2009

Bell Pharmaceuticals, Inc – FDA Inspection, May 15, 2009

Record Details

This FDA Inspection record concerns Bell Pharmaceuticals, Inc, with an inspection on May 15, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Bell Pharmaceuticals, Inc
Inspection Date
May 15, 2009
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · e4f54e43-ffc6-4440-a948-f6ddf11751ae

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
582576
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

11
  1. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  2. 21 CFR 211.160(a)Following/documenting laboratory controls
  3. 21 CFR 211.160(b)Scientifically sound laboratory controls
  4. 21 CFR 211.194(a)(7)Signatures and dates--person who performs test
  5. 21 CFR 211.113(a)Procedures for non-sterile drug products
  6. 21 CFR 211.84(d)(2)Reports of Analysis (Components)
  7. 21 CFR 211.84(d)(1)Identity Testing of Each Component
  8. 21 CFR 211.100(a)Absence of Written Procedures
  9. 21 CFR 211.180(e)(1)Review of representative number of batches
  10. 21 CFR 211.67(b)Written procedures not established/followed

Showing 10 of 11 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Bell Pharmaceuticals, Inc

5
DateClassificationOfficeProject area
June 18, 2025VAIMinneapolis District OfficeDrug Quality Assurance
April 6, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 20, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
April 5, 2013VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 12, 2010NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Bell Pharmaceuticals, Inc
  • FDA Inspection 1271571 - 2025-06-18
  • FDA Inspection 1047160 - 2018-04-06
  • FDA Inspection 955992 - 2015-11-20
  • FDA Inspection 826998 - 2013-04-05
  • FDA Inspection 697960 - 2010-11-12

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Bell Pharmaceuticals, Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.